1173813

Matthew W. Doty, M.D. — FEI 3022537252

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 1, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Miami, FL (United States)

Additional Details

Clinical Investigator (CI)